Virucidal effect of monogalactosyl diacylglyceride from a green microalga, Coccomyxa sp. KJ, against clinical isolates of SARS-CoV-2 as assessed by a plaque assay

J Clin Lab Anal. 2022 Jan;36(1):e24146. doi: 10.1002/jcla.24146. Epub 2021 Nov 27.

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19) and is capable of human-to-human transmission and rapid global spread. Thus, the establishment of high-quality viral detection and quantification methods, and the development of anti-SARS-CoV-2 agents are critical.

Methods: Here, we present the rapid detection of infectious SARS-CoV-2 particles using a plaque assay with 0.5% agarose-ME (Medium Electroosmosis) as an overlay medium.

Results: The plaques were capable of detecting the virus within 36-40 h post-infection. In addition, we showed that a monogalactosyl diacylglyceride isolated from a microalga (Coccomyxa sp. KJ) could inactivate the clinical isolates of SARS-CoV-2 in a time- and concentration-dependent manner.

Conclusions: These results would allow rapid quantification of the infectious virus titers and help develop more potent virucidal agents against SARS-CoV-2.

Keywords: detection time; infectious virus; natural product; quantification; virucidal action.

MeSH terms

  • Animals
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • COVID-19 / virology
  • Chlorocebus aethiops
  • Chlorophyta / chemistry
  • Galactose / analogs & derivatives*
  • Galactose / chemistry
  • Galactose / pharmacology
  • Glycerides / chemistry
  • Glycerides / pharmacology*
  • Humans
  • Microalgae / chemistry*
  • SARS-CoV-2 / drug effects*
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / isolation & purification
  • Vero Cells
  • Viral Plaque Assay

Substances

  • Antiviral Agents
  • Glycerides
  • monogalactosyl diacylglyceride
  • Galactose

Associated data

  • RefSeq/MN908947.3